FindLaw | Legal Professionals | Students | Business | Public | News   E-mail@Justice.com | MY FindLaw 
FindLaw Class Action Center
  Class Action Center | Class Action News | Class Action Notices | Class Action Settlements | Recalls | Legal Research & Practice Ad Info
Home
Accutane
Acetaminophen
Ambien
Aredia
Avandia
Baycol
Benzene
Beryllium
Bextra
Celebrex
Celexa
Cialis
Crestor
Darvon / Darvocet
Depo-Provera
Diclofenac
Drug-Coated Stents
Duragesic Patch
Effexor
Ephedra
Evista
Fen-Phen
Fluvoxamine
Food Poisoning
Fosamax
Gleevec
Guidant Defibrillator
Ketek
Lasik Eye Surgery
Lead Poisoning
Levitra
Lexapro
Light Cigarettes
Medtronic Defibrillator
Meridia
Mesothelioma - Asbestos
Mirapex
MoisturePlus Lens Solution
Motor Vehicle Defects
Neurontin
Ortho Evra Patch
Paxil
Perchlorate
Pergolide (Permax)
Popcorn Lung Illness
Prempro
Promethazine HCl
Prozac
ReNu with MoistureLoc
Risperdal
Seroquel
Serzone
Silicosis & Silica
Spinach Recall and E. coli
Symbyax
Tamiflu
Teflon
Tequin
Trasylol
Triaminic Vapor Patch
Viagra
Vioxx
Welding Rods
Zoloft
Zometa
Zyprexa
Recalls & Safety Alerts
Consumer Products
Food and Drugs
Motor Vehicles
News
Notices
Settlements
Legal Research
Baxter Dialyzers
 Law Firm Listings
  • Click here to request information on how your firm can be listed here.
 FindLaw Message Boards
 Overview

In mid-October, 2001, Baxter International announced that it was voluntarily recalling certain dialyzers after reports of deaths associated with its product in kidney dialysis patients in Spain, Croatia, Italy, Germany, Taiwan, Colombia and the U.S. The first reported deaths occurred in Spain in mid-August. Most of the dialysis patients who died experienced shortness of breath, chest tightness, cardiac arrest or stroke symptoms within hours of being dialyzed.

The following dialyzers - labeled either Althane or Baxter - were recalled:

  • Series A11, A15, A18 and A22
  • Series AF150, AF180 and AF220
  • Series AX1500 and AX2200

According to a Baxter press release issued on November 5, 2001, preliminary tests have led Baxter to conclude that a perfluorohydrocarbon-based performance fluid used in a manufacturing step may have played a role in the deaths of these patients. Additional tests are currently underway.

 Related Information





  FindLaw.com
Advertising Info · Add URL · Help · Comments Jobs@FindLaw · Site Map
Company | Privacy Policy | Disclaimer Copyright © 1994-2008 FindLaw